Key result
Drug-drug interactions with oral anticoagulants, primarily involving CYP450 enzymes and P-glycoprotein, require careful recognition and management to minimize adverse drug reactions and bleeding risks.
Why the study?
Both warfarin and direct oral anticoagulants are susceptible to drug-drug interactions, which are an important cause of adverse drug reactions and exact a large toll on the healthcare system.
Recognition of specific cytochrome P450 and P-glycoprotein drug-drug interactions is essential to minimize adverse events and bleeding risks in patients taking oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Clinicians must integrate DDI screening into OAC prescribing to reduce bleeding; reinforces and extends guideline-directed safety protocols.
Mar et al. (2022) conducted a review in Atrial fibrillation and other cardiovascular conditions. Drug-drug interactions with oral anticoagulants was evaluated. Drug-drug interactions with oral anticoagulants, primarily involving CYP450 enzymes and P-glycoprotein, require careful recognition and management to minimize adverse drug reactions and bleeding risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: